Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.
about
Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese childrenAzithromycin for acute lower respiratory tract infectionsAzithromycin for acute lower respiratory tract infectionsAzithromycin for acute lower respiratory tract infectionsA genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzaeEmerging mechanisms of fluoroquinolone resistanceStudy of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesDeterminants for hospitalization in " low-risk" community acquired pneumoniaBench-to-bedside review: outcome predictions for critically ill patients in the emergency department.Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcusCrystal structure of enoyl-acyl carrier protein reductase (FabK) fromStreptococcus pneumoniaereveals the binding mode of an inhibitorOutcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortalityClinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials GroupFluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F cloneThe role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data.In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia.Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban populationActivities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.A comparative In vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America. The Gemifloxacin Surveillance Study Research GroupFluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.Managing community-acquired pneumonia. Factors to consider in outpatient care.Severe pneumonia. When and why to hospitalize.'Atypical pneumonia'. Why this term may be better left unsaid.Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.Quinolones: which generation for which microbe?Pneumococcal macrolide resistance--myth or reality?The next generation: fluoroquinolones in the management of acute lower respiratory infection in adultsEffectively treating common infections in residents of long-term care facilities.Treatment guideline for nursing home-acquired pneumonia based on community practice.Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patientsClonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study.Nosocomial pneumococcal infection: an outbreak.Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in TaiwanUse of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococciManagement of infections due to antibiotic-resistant Streptococcus pneumoniaeEvaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection
P2860
Q21245788-D49803A6-5944-4481-BE79-CDDD7585AB90Q24187354-355C3884-B5FD-4DB7-B6A6-47D74441D6ADQ24242162-A18AB5FF-6C6D-45F8-85C8-88CA0C4CD130Q24245859-45AFEE63-88D4-42E6-B46B-99FBD19017FDQ24530777-1317C880-F1A8-4B3E-B7D6-74EC1AA217F9Q24644842-E8DB5E85-A263-425A-8E8A-BB151F8E61CEQ24679117-0226BC5F-7C13-40EC-B896-044845352F6AQ24806482-E4E04B9A-9A71-43A4-822D-575D8BE5FE59Q24817051-0ADEBB98-1FFC-4DD3-B2E4-E4C5C4C2ABF2Q27026700-C16D4442-6EC9-4C64-9395-81645A92906AQ27649956-99EA950D-A645-4DED-A9BA-B2E618D41BBFQ28141559-DDD5D815-0DD8-443A-8863-07227C5BFFA3Q28344357-1D9A733E-BE07-400F-8D4A-5A11A210CB7BQ28366621-19219BDA-D0FA-470F-98E0-F28981775BBFQ30577239-8C14222D-59A2-44FA-8DCF-70181854A4E2Q30612482-5336C075-50C5-4FC4-8611-DF69F77642BAQ31004673-D4C6AD96-D96B-4629-9832-4058339F746EQ33181645-D516DADF-1B99-4301-80E1-EC37C61B3FA7Q33418963-F7302C8D-0010-44D7-911F-4D75F6D6D36DQ33593776-C55894FA-6435-4C19-BEE0-B185CAB4E7F1Q33593962-858A4259-E7E4-423D-94FD-3AD8EA6B268EQ33594174-EAA004CA-EA60-41FA-BE3C-F5E5DF06FE8CQ33605253-E8415410-C157-4326-A2C2-BAA608D4DCB2Q33605257-D09041DE-471F-4B68-A964-BC2E8F35429CQ33605262-266174EC-135C-4E44-B657-5A507C3F2951Q33654539-EF6C89EF-3145-40A0-BC4A-63C6D9E375CEQ33686219-3002286E-E79A-415C-8837-3DAD2CF8C24BQ33708968-D77991F2-8680-4748-A1CE-A93AC733B564Q33718858-0A698F6C-F5E5-48FB-A470-45BFA05D68A8Q33801878-253C1A1F-FFE3-4F47-872E-E86C2E4C8CF1Q33803420-AFDD2F06-8402-499D-9876-73851B67E123Q33821368-15F3F142-09CF-4A02-9C57-7380EC0A402DQ33857395-05588A1F-AA97-45D0-8A69-500F7829CD8FQ33885194-CB5BA905-37C5-4978-8844-BEAC33B203B6Q33970496-093A7C32-9033-42A7-A871-11B2468DE328Q33972802-4AC9FE78-1F41-49D6-BCEC-B3C3B5193581Q33974488-56B65A3E-34FB-4890-805F-C7E0964E7153Q33974710-3A0F905A-5A42-4F4D-9351-CFE60A76C5F2Q33975374-A75BE125-4841-4DE1-B745-093B2D6F1B80Q33977440-8619F956-D050-4EA4-87AC-FD8FB5958C23
P2860
Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Community-acquired pneumonia i ...... s Diseases Society of America.
@en
type
label
Community-acquired pneumonia i ...... s Diseases Society of America.
@en
prefLabel
Community-acquired pneumonia i ...... s Diseases Society of America.
@en
P2093
P356
P1476
Community-acquired pneumonia i ...... s Diseases Society of America.
@en
P2093
Bartlett JG
Breiman RF
File TM Jr
Mandell LA
P304
P356
10.1086/513953
P407
P577
1998-04-01T00:00:00Z